BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuniholm MH, Lesi OA, Mendy M, Akano AO, Sam O, Hall AJ, Whittle H, Bah E, Goedert JJ, Hainaut P, Kirk GD. Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa. Environ Health Perspect 2008;116:1553-7. [PMID: 19057710 DOI: 10.1289/ehp.11661] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Robles AI, Harris CC. Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol. 2010;2:a001016. [PMID: 20300207 DOI: 10.1101/cshperspect.a001016] [Cited by in Crossref: 155] [Cited by in F6Publishing: 157] [Article Influence: 12.9] [Reference Citation Analysis]
2 da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA. Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int J Cancer. 2015;136:172-181. [PMID: 24803312 DOI: 10.1002/ijc.28953] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
3 Umoh NJ, Lesi OA, Mendy M, Bah E, Akano A, Whittle H, Hainaut P, Kirk GD. Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia. Liver Int 2011;31:215-21. [PMID: 21143369 DOI: 10.1111/j.1478-3231.2010.02418.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
4 Rabadán A, Triguero Á. Influence of food safety standards on trade: Evidence from the pistachio sector. Agribusiness 2021;37:489-514. [DOI: 10.1002/agr.21683] [Reference Citation Analysis]
5 Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2010;31:71-82. [PMID: 19875698 DOI: 10.1093/carcin/bgp264] [Cited by in Crossref: 513] [Cited by in F6Publishing: 407] [Article Influence: 39.5] [Reference Citation Analysis]
6 Mendy ME, Welzel T, Lesi OA, Hainaut P, Hall AJ, Kuniholm MH, McConkey S, Goedert JJ, Kaye S, Rowland-Jones S, Whittle H, Kirk GD. Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa. J Viral Hepat. 2010;17:115-122. [PMID: 19874478 DOI: 10.1111/j.1365-2893.2009.01168.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
7 Ladep NG. Why is the Tumour Different in Africa? In: Williams R, Taylor-robinson SD, editors. Clinical Dilemmas in Primary Liver Cancer. Oxford: Wiley-Blackwell; 2011. pp. 11-7. [DOI: 10.1002/9781119962205.ch2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Thompson LA, Darwish WS. Environmental Chemical Contaminants in Food: Review of a Global Problem. J Toxicol 2019;2019:2345283. [PMID: 30693025 DOI: 10.1155/2019/2345283] [Cited by in Crossref: 74] [Cited by in F6Publishing: 50] [Article Influence: 24.7] [Reference Citation Analysis]
9 Traoré F, Gormally E, Villar S, Friesen MD, Groopman JD, Vernet G, Diallo S, Hainaut P, Maiga MY. Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali. BMC Infect Dis 2015;15:180. [PMID: 25886382 DOI: 10.1186/s12879-015-0916-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 Torres O, Matute J, Gelineau-van Waes J, Maddox J, Gregory S, Ashley-koch A, Showker J, Voss K, Riley R. Human health implications from co-exposure to aflatoxins and fumonisins in maize-based foods in Latin America: Guatemala as a case study. World Mycotoxin Journal 2015;8:143-59. [DOI: 10.3920/wmj2014.1736] [Cited by in Crossref: 44] [Article Influence: 6.3] [Reference Citation Analysis]
11 Chang Y, Tolani B, Nie X, Zhi X, Hu M, He B. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. Ther Clin Risk Manag 2017;13:1363-74. [PMID: 29066904 DOI: 10.2147/TCRM.S141991] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
12 Wang X, Lin SX, Tao J, Wei XQ, Liu YT, Chen YM, Wu B. Study of liver cirrhosis over ten consecutive years in Southern China. World J Gastroenterol 2014; 20(37): 13546-13555 [PMID: 25309085 DOI: 10.3748/wjg.v20.i37.13546] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
13 Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis. 2012;33:1219-1224. [PMID: 22759751 DOI: 10.1093/carcin/bgs068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wang WH, Jiang CL, Yan W, Zhang YH, Yang JT, Zhang C, Yan B, Zhang W, Han W, Wang JZ, Zhang YQ. FOXP3 expression and clinical characteristics of hepatocellular carcinoma. World J Gastroenterol 2010; 16(43): 5502-5509 [PMID: 21086571 DOI: 10.3748/wjg.v16.i43.5502] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
15 Alvarez CS, Hernández E, Escobar K, Villagrán CI, Kroker-Lobos MF, Rivera-Andrade A, Smith JW, Egner PA, Lazo M, Freedman ND, Guallar E, Dean M, Graubard BI, Groopman JD, Ramírez-Zea M, McGlynn KA. Aflatoxin B1 exposure and liver cirrhosis in Guatemala: a case-control study. BMJ Open Gastroenterol 2020;7:e000380. [PMID: 32641287 DOI: 10.1136/bmjgast-2020-000380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wu F, Guclu H. Aflatoxin regulations in a network of global maize trade. PLoS One 2012;7:e45151. [PMID: 23049773 DOI: 10.1371/journal.pone.0045151] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
17 Wu F, Khlangwiset P. Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010;27:658-76. [PMID: 20455160 DOI: 10.1080/19440041003639582] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
18 Gelband H, Chen C, Chen W, Franceschi S, Hall SA, London WT, Mcglynn KA, Wild CP. Liver Cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Disease Control Priorities, Third Edition (Volume 3): Cancer. The World Bank; 2015. pp. 147-64. [DOI: 10.1596/978-1-4648-0349-9_ch8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
19 Mekuria AN, Routledge MN, Gong YY, Sisay M. Aflatoxins as a risk factor for liver cirrhosis: a systematic review and meta-analysis. BMC Pharmacol Toxicol 2020;21:39. [PMID: 32487162 DOI: 10.1186/s40360-020-00420-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
20 Adaku Chilaka C, Mally A. Mycotoxin Occurrence, Exposure and Health Implications in Infants and Young Children in Sub-Saharan Africa: A Review. Foods 2020;9:E1585. [PMID: 33139646 DOI: 10.3390/foods9111585] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
21 Zhu S, Li Y, Zhang Y, Wang X, Gong L, Han X, Yao L, Lan M, Zhang W. Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma. Hepatol Res 2015;45:97-106. [PMID: 24593119 DOI: 10.1111/hepr.12320] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
22 Gouas DA, Villar S, Ortiz-Cuaran S, Legros P, Ferro G, Kirk GD, Lesi OA, Mendy M, Bah E, Friesen MD. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis. 2012;33:1219-1224. [PMID: 22759751 DOI: 10.1093/carcin/bgs135] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
23 Kew MC. Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis. World J Hepatol 2010; 2(2): 65-73 [PMID: 21160975 DOI: 10.4254/wjh.v2.i2.65] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
24 Mukhula V, Sibale D, Tarmahomed L, Dzamalala C, Msyamboza K, Chasimpha S. Characterising cancer burden and quality of care at two palliative care clinics in Malawi. Malawi Med J 2017;29:130-5. [PMID: 28955420 DOI: 10.4314/mmj.v29i2.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Luo CS, Lin Y, Zhou WP, Shi J. Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis. Eur J Gastroenterol Hepatol 2020;32:1030-5. [PMID: 31764404 DOI: 10.1097/MEG.0000000000001610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ladep NG, Lesi OA, Mark P, Lemoine M, Onyekwere C, Afihene M, Crossey MM, Taylor-Robinson SD. Problem of hepatocellular carcinoma in West Africa. World J Hepatol 2014; 6(11): 783-792 [PMID: 25429316 DOI: 10.4254/wjh.v6.i11.783] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
27 Ortega-Beltran A, Kaptoge L, Senghor AL, Aikore MOS, Jarju P, Momanyi H, Konlambigue M, Falade TDO, Bandyopadhyay R. Can it be all more simple? Manufacturing aflatoxin biocontrol products using dry spores of atoxigenic isolates of Aspergillus flavus as active ingredients. Microb Biotechnol 2021. [PMID: 33755307 DOI: 10.1111/1751-7915.13802] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Grace D, Mahuku G, Hoffmann V, Atherstone C, Upadhyaya HD, Bandyopadhyay R. International agricultural research to reduce food risks: case studies on aflatoxins. Food Sec 2015;7:569-82. [DOI: 10.1007/s12571-015-0469-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 10] [Article Influence: 6.1] [Reference Citation Analysis]
29 Chu YJ, Yang HI, Wu HC, Liu J, Wang LY, Lu SN, Lee MH, Jen CL, You SL, Santella RM, Chen CJ. Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers. Int J Cancer. 2017;141:711-720. [PMID: 28509392 DOI: 10.1002/ijc.30782] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
30 Wang XZ, Huang XY, Yao JG, Wang C, Xia Q, Long XD. Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1. Oncotarget 2018;9:27321-32. [PMID: 29937988 DOI: 10.18632/oncotarget.24535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cohen D, Shimakawa Y, Ndow G, Sow A, Tamba S, Njie R, Lo G, Ghosh S, Toure-Kane C, Ka M, Mboup S, Okeke E, Toure S, Diop M, D'Alessandro U, Taylor-Robinson S, Mendy M, Zoulim F, Thursz MR, Lemoine M, Chemin I. [Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]. Med Sci (Paris) 2019;35:431-9. [PMID: 31115326 DOI: 10.1051/medsci/2019076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Jaquet A, Wandeler G, Tine J, Dagnra CA, Attia A, Patassi A, Ndiaye A, de Ledinghen V, Ekouevi DK, Seydi M, Dabis F. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa. BMC Infect Dis 2016;16:249. [PMID: 27267370 DOI: 10.1186/s12879-016-1601-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
33 Pollock BH, Elmore S, Romoser A, Tang L, Kang MS, Xue K, Rodriguez M, Dierschke NA, Hayes HG, Hansen HA, Guerra F, Wang JS, Phillips T. Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2016;33:1346-54. [PMID: 27321368 DOI: 10.1080/19440049.2016.1198498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
34 Andrade P, de Mello MH, França J, Caldas E. Aflatoxins in food products consumed in Brazil: a preliminary dietary risk assessment. Food Additives & Contaminants: Part A 2013;30:127-36. [DOI: 10.1080/19440049.2012.720037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
35 Wandeler G, Mulenga L, Vinikoor MJ, Kovari H, Battegay M, Calmy A, Cavassini M, Bernasconi E, Schmid P, Bolton-Moore C, Sinkala E, Chi BH, Egger M, Rauch A; for IeDEA-Southern Africa and the Swiss HIV Cohort Study. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. Int J Infect Dis 2016;51:97-102. [PMID: 27596685 DOI: 10.1016/j.ijid.2016.08.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
36 Darwish WS, Ikenaka Y, Nakayama SM, Ishizuka M. An overview on mycotoxin contamination of foods in Africa. J Vet Med Sci 2014;76:789-97. [PMID: 24572628 DOI: 10.1292/jvms.13-0563] [Cited by in Crossref: 74] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
37 Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Ndyanabo A, Kiggundu V, Boaz I, Gray RH, Wawer M, Thio C, Thomas DL, Quinn TC, Kirk GD; Rakai Health Sciences Program. High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther 2011;16:405-11. [PMID: 21555823 DOI: 10.3851/IMP1783] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
38 Schrenk D, Bignami M, Bodin L, Chipman JK, Del Mazo J, Grasl-Kraupp B, Hogstrand C, Hoogenboom LR, Leblanc JC, Nebbia CS, Nielsen E, Ntzani E, Petersen A, Sand S, Schwerdtle T, Vleminckx C, Marko D, Oswald IP, Piersma A, Routledge M, Schlatter J, Baert K, Gergelova P, Wallace H; EFSA Panel on Contaminants in the Food Chain (CONTAM). Risk assessment of aflatoxins in food. EFSA J 2020;18:e06040. [PMID: 32874256 DOI: 10.2903/j.efsa.2020.6040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
39 Andrews FV, Smit E, Welch BM, Ahmed SM, Kile ML. Urinary polycyclic aromatic hydrocarbons concentrations and hepatitis B antibody serology in the United States (NHANES, 2003-2014). Environ Res 2021;195:110801. [PMID: 33539830 DOI: 10.1016/j.envres.2021.110801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 O'Hara G, Mokaya J, Hau JP, Downs LO, McNaughton AL, Karabarinde A, Asiki G, Seeley J, Matthews PC, Newton R. Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors. BMJ Open 2020;10:e032890. [PMID: 32234740 DOI: 10.1136/bmjopen-2019-032890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]